Anixa Biosciences Inc
ANIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000715446
In the last 90 days, Anixa Biosciences Inc insiders filed 14 open-market purchases and 0 sales; 63 institutions reported holding it in 13F filings for Q2 2026, worth $15.0M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Anixa Biosciences Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 14 filings
- 3 insiders, $354.3K in total
- Open-market sells
- 0 filings
- Insiders trading
- 3
- Net value
- +$354.3K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Anixa Biosciences Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Kumar Amit | Chief Executive Officer | 672,000 | Sep 28, 2026 | 12 |
| Baskies Arnold M | Director | 140,572 | Sep 28, 2026 | 4 |
| Titterton Lewis H jr | Director | 1,046,003 | Sep 25, 2026 | 7 |
| Catelani Michael | President, COO & CFO | 44,500 | Jan 6, 2026 | 1 |
| Gottschalk Emily | Director | 45,665 | Jan 6, 2026 | 1 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 10, 2022 (view filing) | Jan 7 | 3 days | Titterton Lewis H jrDirector | PPurchase | +11.0K | $3.08 | +$33.9K | +1.2%965.1K after | |
| Jan 7, 2022 (view filing) | Jan 7 | Same day | Kumar AmitChief Executive Officer | PPurchase | +20.0K | $3.00 | +$60.0K | +6.8%314.0K after | |
| Nov 1, 2021 (view filing) | Oct 29 | 3 days | Titterton Lewis H jrDirector | PPurchase | +18.2K | $4.76 | +$86.8K | +1.9%954.1K after | |
| Nov 1, 2021 (view filing) | Oct 29 | 3 days | Kumar AmitChief Executive Officer | PPurchase | +2.00K | $4.77 | +$9.54K | +0.7%294.0K after | |
| Jul 28, 2021 (view filing) | Jul 26 | 2 days | Titterton Lewis H jrDirector | PPurchase | +30.0K | $4.21 | +$126.3K | +3.3%935.8K after | |
| Jul 27, 2021 (view filing) | Jul 23 | 4 days | Kumar AmitChief Executive Officer | PPurchase | +5.00K | $4.28 | +$21.4K | +1.7%292.0K after | |
| Jul 27, 2021 (view filing) | Jul 23 | 4 days | Baskies Arnold MDirector | PPurchase | +19.0K | $4.33 | +$82.3K | +23.5%100.0K after | |
| Jul 20, 2021 (view filing) | Jul 16 | 4 days | Kumar AmitChief Executive Officer | PPurchase | +10.0K | $3.94 | +$39.4K | +3.6%287.0K after | |
| Jul 19, 2021 (view filing) | Jul 15-16 | 4 days | Titterton Lewis H jrDirector | PPurchase | +12.2K | $3.99 | +$48.7K | +1.4%905.8K after | 2 lots |
| Jul 16, 2021 (view filing) | Jul 15 | 1 day | Gottschalk EmilyDirector | PPurchase | +20.1K | $3.96 | +$79.5K | +78.4%45.7K after | |
| Jul 16, 2021 (view filing) | Jul 15 | 1 day | Baskies Arnold MDirector | PPurchase | +20.0K | $3.90 | +$78.0K | +32.8%81.0K after | |
| Jul 15, 2021 (view filing) | Jul 14 | 1 day | Titterton Lewis H jrDirector | PPurchase | +23.3K | $3.72 | +$86.7K | +2.7%893.6K after |